Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

NDRG2: a novel Alzheimer's disease associated protein.

Mitchelmore C, Büchmann-Møller S, Rask L, West MJ, Troncoso JC, Jensen NA.

Neurobiol Dis. 2004 Jun;16(1):48-58.

PMID:
15207261
2.

The novel cytosolic RING finger protein dactylidin is up-regulated in brains of patients with Alzheimer's disease.

von Rotz RC, Kins S, Hipfel R, von der Kammer H, Nitsch RM.

Eur J Neurosci. 2005 Mar;21(5):1289-98.

PMID:
15813938
3.

Neuronal pentraxin 1 contributes to the neuronal damage evoked by amyloid-beta and is overexpressed in dystrophic neurites in Alzheimer's brain.

Abad MA, Enguita M, DeGregorio-Rocasolano N, Ferrer I, Trullas R.

J Neurosci. 2006 Dec 6;26(49):12735-47.

4.

Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.

Ferrer I, Gomez-Isla T, Puig B, Freixes M, Ribé E, Dalfó E, Avila J.

Curr Alzheimer Res. 2005 Jan;2(1):3-18. Review.

PMID:
15977985
5.

Reelin depletion in the entorhinal cortex of human amyloid precursor protein transgenic mice and humans with Alzheimer's disease.

Chin J, Massaro CM, Palop JJ, Thwin MT, Yu GQ, Bien-Ly N, Bender A, Mucke L.

J Neurosci. 2007 Mar 14;27(11):2727-33.

6.

mTOR/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer's disease.

Lafay-Chebassier C, Paccalin M, Page G, Barc-Pain S, Perault-Pochat MC, Gil R, Pradier L, Hugon J.

J Neurochem. 2005 Jul;94(1):215-25.

7.
8.

Hematopoietic prostaglandin D synthase and DP1 receptor are selectively upregulated in microglia and astrocytes within senile plaques from human patients and in a mouse model of Alzheimer disease.

Mohri I, Kadoyama K, Kanekiyo T, Sato Y, Kagitani-Shimono K, Saito Y, Suzuki K, Kudo T, Takeda M, Urade Y, Murayama S, Taniike M.

J Neuropathol Exp Neurol. 2007 Jun;66(6):469-80.

9.

Abeta immunotherapy protects morphology and survival of adult-born neurons in doubly transgenic APP/PS1 mice.

Biscaro B, Lindvall O, Hock C, Ekdahl CT, Nitsch RM.

J Neurosci. 2009 Nov 11;29(45):14108-19. doi: 10.1523/JNEUROSCI.2055-09.2009.

10.

Activated double-stranded RNA-dependent protein kinase and neuronal death in models of Alzheimer's disease.

Page G, Rioux Bilan A, Ingrand S, Lafay-Chebassier C, Pain S, Perault Pochat MC, Bouras C, Bayer T, Hugon J.

Neuroscience. 2006;139(4):1343-54. Epub 2006 Apr 3.

PMID:
16581193
11.

Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis.

Zhao J, Fu Y, Yasvoina M, Shao P, Hitt B, O'Connor T, Logan S, Maus E, Citron M, Berry R, Binder L, Vassar R.

J Neurosci. 2007 Apr 4;27(14):3639-49.

12.

Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.

Jack CR Jr, Marjanska M, Wengenack TM, Reyes DA, Curran GL, Lin J, Preboske GM, Poduslo JF, Garwood M.

Neuroscientist. 2007 Feb;13(1):38-48. Review.

PMID:
17229974
14.

[Alzheimer disease: cellular and molecular aspects].

Octave JN.

Bull Mem Acad R Med Belg. 2005;160(10-12):445-9; discussion 450-1. French.

PMID:
16768248
15.

Changes in readthrough acetylcholinesterase expression modulate amyloid-beta pathology.

Berson A, Knobloch M, Hanan M, Diamant S, Sharoni M, Schuppli D, Geyer BC, Ravid R, Mor TS, Nitsch RM, Soreq H.

Brain. 2008 Jan;131(Pt 1):109-19. Epub 2007 Dec 3.

16.

The pathology of APP transgenic mice: a model of Alzheimer's disease or simply overexpression of APP?

Howlett DR, Richardson JC.

Histol Histopathol. 2009 Jan;24(1):83-100. Review.

PMID:
19012248
17.

Neuronal expression of vimentin in the Alzheimer's disease brain may be part of a generalized dendritic damage-response mechanism.

Levin EC, Acharya NK, Sedeyn JC, Venkataraman V, D'Andrea MR, Wang HY, Nagele RG.

Brain Res. 2009 Nov 17;1298:194-207. doi: 10.1016/j.brainres.2009.08.072. Epub 2009 Sep 1.

PMID:
19728994
18.

Presenilin mutations in familial Alzheimer disease and transgenic mouse models accelerate neuronal lysosomal pathology.

Cataldo AM, Peterhoff CM, Schmidt SD, Terio NB, Duff K, Beard M, Mathews PM, Nixon RA.

J Neuropathol Exp Neurol. 2004 Aug;63(8):821-30.

19.
20.

Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.

Pérez M, Morán MA, Ferrer I, Avila J, Gómez-Ramos P.

Acta Neuropathol. 2008 Oct;116(4):409-18. doi: 10.1007/s00401-008-0420-0. Epub 2008 Aug 5.

PMID:
18679696
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk